Related Experiment Videos
The androgen receptor: structure, mutations, and antiandrogens.
Samit Hirawat1, Daniel R Budman, Willi Kreis
1Don Monti Division of Medical Oncology/Division of Hematology, Department of Medicine, North Shore University Hospital-NYU School of Medicine, Manhasset, New York, USA.
Cancer Investigation
|August 7, 2003
Summary
Androgen receptor (AR) mutations impact prostate cancer development and treatment. Understanding AR function and developing targeted therapies are crucial for managing advanced prostate cancer.
Area of Science:
- Endocrinology
- Molecular Biology
- Oncology
Background:
- Androgens are vital for prostate development and prostate cancer genesis.
- The androgen receptor (AR) mediates androgen effects and is a key target in prostate cancer therapy.
Purpose of the Study:
- To explore the role of the androgen receptor in prostate cancer.
- To discuss current and future therapeutic strategies targeting the androgen pathway.
Main Methods:
- Review of the androgen receptor's structure, function, and activation pathways.
- Analysis of mutations affecting AR function and treatment response.
- Discussion of antiandrogen therapies and novel treatment approaches.
Main Results:
- AR mutations can alter receptor function, impacting treatment efficacy.
- Antiandrogens are standard for advanced prostate cancer palliation.
- Intermittent androgen suppression may overcome resistance mechanisms.
Conclusions:
- AR signaling is central to prostate cancer.
- Targeting AR, including through novel strategies like intermittent suppression, is essential for improving patient outcomes.
- Future research aims to develop drugs that suppress androgen-driven tumors and enhance sensitivity to cytotoxic agents.